{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:53:34Z","timestamp":1782496414112,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004032","name":"Jilin University","doi-asserted-by":"publisher","award":["JDYY14202319"],"award-info":[{"award-number":["JDYY14202319"]}],"id":[{"id":"10.13039\/501100004032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017585","name":"First Hospital of Jilin University","doi-asserted-by":"publisher","award":["JDYY-DEP-2023025"],"award-info":[{"award-number":["JDYY-DEP-2023025"]}],"id":[{"id":"10.13039\/501100017585","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jare.2025.10.073","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:32:04Z","timestamp":1762212724000},"page":"1085-1098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Diagnostic and therapeutic potential of resolvin D1 in Guillain\u2013Barr\u00e9 syndrome"],"prefix":"10.1016","volume":"85","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangding","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2025.10.073_b0005","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jare.2025.10.073_b0010","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41582-024-01014-1","article-title":"NMOSD and MOGAD: an evolving disease spectrum","volume":"20","author":"Uzawa","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jare.2025.10.073_b0015","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barre syndrome","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jare.2025.10.073_b0020","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16365","article-title":"Guillain-Barr\u00e9 syndrome: a comprehensive review","volume":"31","author":"Bellanti","year":"2024","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jare.2025.10.073_b0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jare.2025.10.073_b0030","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.scib.2024.07.049","article-title":"Specialized pro-resolving lipid mediators: a key player in resolving inflammation in autoimmune diseases","volume":"70","author":"Zhang","year":"2025","journal-title":"Sci Bull (Beijing)"},{"key":"10.1016\/j.jare.2025.10.073_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103896","article-title":"Specialized pro-resolving mediators and autoimmunity: recent insights and future perspectives","volume":"24","author":"Vomero","year":"2025","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jare.2025.10.073_b0040","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1074\/jbc.M300218200","article-title":"Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells, Autacoids in anti-inflammation","volume":"278","author":"Hong","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2025.10.073_b0045","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals","volume":"196","author":"Serhan","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.jare.2025.10.073_b0050","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1073\/pnas.0907342107","article-title":"Resolvin D1 binds human phagocytes with evidence for proresolving receptors","volume":"107","author":"Krishnamoorthy","year":"2010","journal-title":"PNAS"},{"key":"10.1016\/j.jare.2025.10.073_b0055","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1056\/NEJMp2310178","article-title":"What is Rheumatoid Arthritis?","volume":"390","author":"Gravallese","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jare.2025.10.073_b0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13075-020-2133-2","article-title":"Resolvin D1 suppresses pannus formation via decreasing connective tissue growth factor caused by upregulation of miRNA-146a-5p in rheumatoid arthritis","volume":"22","author":"Sun","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jare.2025.10.073_b0065","doi-asserted-by":"crossref","DOI":"10.7326\/AITC202006020","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jare.2025.10.073_b0070","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5264195","article-title":"Role of the specialized proresolving mediator resolvin D1 in systemic lupus erythematosus: preliminary results","volume":"2018","author":"Navarini","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jare.2025.10.073_b0075","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","article-title":"A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking","volume":"73","author":"Teunissen","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jare.2025.10.073_b0080","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.jare.2025.10.073_b0085","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/mus.880141111","article-title":"Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barre syndrome","volume":"14","author":"Kleyweg","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jare.2025.10.073_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.668760","article-title":"Resolvin D1 improves the Treg\/Th17 imbalance in systemic lupus erythematosus through miR-30e-5p","volume":"12","author":"Cheng","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jare.2025.10.073_b0095","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.3324\/haematol.2019.219519","article-title":"Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction","volume":"105","author":"Kooij","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jare.2025.10.073_b0100","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","article-title":"Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study","volume":"21","author":"Benkert","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jare.2025.10.073_b0105","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10571-022-01216-5","article-title":"Cerebrospinal fluid profile of lipid mediators in Alzheimer's disease","volume":"43","author":"Do","year":"2023","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.jare.2025.10.073_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105694","article-title":"Resolvin D1 (RvD1) and maresin 1 (Mar1) contribute to human macrophage control of M. tuberculosis infection while resolving inflammation","volume":"74","author":"Ruiz","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jare.2025.10.073_b0115","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10281","article-title":"Resolvin D1-loaded nanoliposomes promote M2 macrophage polarization and are effective in the treatment of osteoarthritis","volume":"7","author":"Dravid","year":"2022","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.jare.2025.10.073_b0120","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1111\/bph.15897","article-title":"RvD1 disrupts nociceptor neuron and macrophage activation and neuroimmune communication, reducing pain and inflammation in gouty arthritis in mice","volume":"179","author":"Zaninelli","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jare.2025.10.073_b0125","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1167\/iovs.14-14356","article-title":"The resolvin D1 analogue controls maturation of dendritic cells and suppresses alloimmunity in corneal transplantation","volume":"55","author":"Hua","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jare.2025.10.073_b0130","article-title":"Resolvin D1 prevents injurious neutrophil swarming in transplanted lungs","volume":"120","author":"Li","year":"2023","journal-title":"PNAS"},{"key":"10.1016\/j.jare.2025.10.073_b0135","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41577-022-00787-0","article-title":"Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases","volume":"23","author":"Wigerblad","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jare.2025.10.073_b0140","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12964-024-01641-7","article-title":"Emerging strategies for treating autoimmune disease with genetically modified dendritic cells","volume":"22","author":"Ma","year":"2024","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.jare.2025.10.073_b0145","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf7483","article-title":"Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses","volume":"8","author":"Chiurchiu","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jare.2025.10.073_b0150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fphys.2020.00285","article-title":"Resolvin D1 protects against ischemia\/reperfusion-induced acute kidney injury by increasing Treg percentages via the ALX\/FPR2 pathway","volume":"11","author":"Luan","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.jare.2025.10.073_b0155","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/318621","article-title":"Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis","volume":"2012","author":"Settimio","year":"2012","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jare.2025.10.073_b0160","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1172\/JCI97951","article-title":"Key roles for lipid mediators in the adaptive immune response","volume":"128","author":"Duffney","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jare.2025.10.073_b0165","doi-asserted-by":"crossref","first-page":"873","DOI":"10.4103\/NRR.NRR-D-23-01688","article-title":"Pro-resolving lipid mediator reduces amyloid-beta42-induced gene expression in human monocyte-derived microglia","volume":"20","author":"Wang","year":"2025","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.jare.2025.10.073_b0170","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/JPER.22-0462","article-title":"Resolvin D1 modulates periodontal ligament fibroblast function","volume":"94","author":"Zarrough","year":"2023","journal-title":"J Periodontol"},{"key":"10.1016\/j.jare.2025.10.073_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1086930","article-title":"Resolvin D1 improves allograft osteointegration and directly enhances osteoblasts differentiation","volume":"14","author":"Pinto","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jare.2025.10.073_b0180","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137713","article-title":"Resolvin D1 supports skeletal myofiber regeneration via actions on myeloid and muscle stem cells","volume":"5","author":"Markworth","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jare.2025.10.073_b0185","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat Med"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225008689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225008689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:31:18Z","timestamp":1782495078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123225008689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"alternative-id":["S2090123225008689"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2025.10.073","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic and therapeutic potential of resolvin D1 in Guillain\u2013Barr\u00e9 syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2025.10.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}